Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Ferrand

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Medecine Sciences : M/S|July 6, 2019
[IL-1RAP as a candidate for CAR T-cells immunotherapy]Mathieu Neto Da Rocha, Rim Trad, Walid Warda, et al.
Molecular Medicine Reports|January 29, 2016
Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinomaTao Wu, Céline Leboeuf, Sarah Durand, et al.
Blood|August 1, 2002
Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cellsMakoto Otsu, Marcos Steinberg, Christophe Ferrand, et al.
Rheumatology (Oxford, England)|June 29, 2015
The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritisClémentine Gamonet, Marina Deschamps, Sandrine Marion, et al.
International Journal of Molecular Sciences|December 11, 2022
IL-1RAP, a Key Therapeutic Target in CancerJame Frenay, Pierre-Simon Bellaye, Alexandra Oudot, et al.
Stem Cells (Dayton, Ohio)|November 13, 2004
Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient miceSarit Samira, Christophe Ferrand, Amnon Peled, et al.
Experimental Hematology|February 21, 2007
B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitroZhao-Yang Lu, Maud Condomines, Karin Tarte, et al.
Leukemia Research Reports|December 28, 2013
A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinibSuella Martino, Etienne Daguindau, Christophe Ferrand, et al.
Kidney International|May 11, 2005
Relevance of Toll-like receptor-4 polymorphisms in renal transplantationDidier Ducloux, Marina Deschamps, Maria Yannaraki, et al.
Transfusion|August 30, 2007
Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized studyValérie Lapierre, Anne Aupérin, Eric Robinet, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Medecine Sciences : M/S|July 6, 2019
[IL-1RAP as a candidate for CAR T-cells immunotherapy]Mathieu Neto Da Rocha, Rim Trad, Walid Warda, et al.
Molecular Medicine Reports|January 29, 2016
Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinomaTao Wu, Céline Leboeuf, Sarah Durand, et al.
Blood|August 1, 2002
Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cellsMakoto Otsu, Marcos Steinberg, Christophe Ferrand, et al.
Rheumatology (Oxford, England)|June 29, 2015
The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritisClémentine Gamonet, Marina Deschamps, Sandrine Marion, et al.
International Journal of Molecular Sciences|December 11, 2022
IL-1RAP, a Key Therapeutic Target in CancerJame Frenay, Pierre-Simon Bellaye, Alexandra Oudot, et al.
Stem Cells (Dayton, Ohio)|November 13, 2004
Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient miceSarit Samira, Christophe Ferrand, Amnon Peled, et al.
Experimental Hematology|February 21, 2007
B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitroZhao-Yang Lu, Maud Condomines, Karin Tarte, et al.
Leukemia Research Reports|December 28, 2013
A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinibSuella Martino, Etienne Daguindau, Christophe Ferrand, et al.
Kidney International|May 11, 2005
Relevance of Toll-like receptor-4 polymorphisms in renal transplantationDidier Ducloux, Marina Deschamps, Maria Yannaraki, et al.
Transfusion|August 30, 2007
Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized studyValérie Lapierre, Anne Aupérin, Eric Robinet, et al.
Pageof 11